Calgary, Alberta--(Newsfile Corp. - October 7, 2025) - Hemostemix (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is…
New research from Black Book benchmarks U.S. healthcare's ROI technology landscape - complimentary report now available to providers and payers.…
WATKINSVILLE, GA / ACCESS Newswire / October 7, 2025 / As rural hospitals across the United States grapple with mounting…
ATLANTA, GEORGIA / ACCESS Newswire / October 7, 2025 / Dogwood Therapeutics, Inc. (Nasdaq:DWTX) (the "Company"), a development-stage biotechnology company…
BOULDER, COLORADO / ACCESS Newswire / October 7, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and…
NEW HAVEN, CONNECTICUT / ACCESS Newswire / October 7, 2025 / Momentum Consulting today announced a new collaboration with clinical…
Icotrokinra met the primary endpoint of clinical response at all three doses, with 36.5% of patients treated achieving endoscopic improvement…
EXECUTIVE CHAIRMAN & CEO OF MEDICUS TO PARTICIPATE IN A PANEL DISCUSSIONThe Summit theme "unlocking the $1 Trillion Wealth transfer…
Findings show that Telomir-1 restores the body's natural tumor suppressor defenses by reversing abnormal DNA methylation of MASPIN and RASSF1A…
Celebrating the vital role pharmacists play in patient health PALM SPRINGS, CALIFORNIA / ACCESS Newswire / October 7, 2025 /…